These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 27919199)

  • 1. Predictive factors associated with the progression of large-joint destruction in patients with rheumatoid arthritis after biologic therapy: A post-hoc analysis using FDG-PET/CT and the ARASHI (assessment of rheumatoid arthritis by scoring of large-joint destruction and healing in radiographic imaging) scoring method.
    Suto T; Yonemoto Y; Okamura K; Okura C; Kaneko T; Kobayashi T; Tachibana M; Tsushima Y; Takagishi K
    Mod Rheumatol; 2017 Sep; 27(5):820-827. PubMed ID: 27919199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of Large Joint Destruction in Patients With Rheumatoid Arthritis Using 18F-FDG PET/CT and Disease Activity Score.
    Suto T; Okamura K; Yonemoto Y; Okura C; Tsushima Y; Takagishi K
    Medicine (Baltimore); 2016 Feb; 95(7):e2841. PubMed ID: 26886646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a new radiographic scoring system to evaluate bone and cartilage destruction and healing of large joints with rheumatoid arthritis: ARASHI (Assessment of rheumatoid arthritis by scoring of large joint destruction and healing in radiographic imaging) study.
    Kaneko A; Matsushita I; Kanbe K; Arai K; Kuga Y; Abe A; Matsumoto T; Nakagawa N; Nishida K
    Mod Rheumatol; 2013 Nov; 23(6):1053-62. PubMed ID: 23624939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of golimumab for preventing large joint destruction in patients with rheumatoid arthritis as determined by the ARASHI score.
    Kanbe K; Oh K; Chiba J; Inoue Y; Taguchi M; Yabuki A
    Mod Rheumatol; 2017 Nov; 27(6):938-945. PubMed ID: 28121204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [18F]fluorodeoxyglucose uptake as a predictor of large joint destruction in patients with rheumatoid arthritis.
    Yonemoto Y; Okamura K; Takeuchi K; Kaneko T; Kobayashi T; Okura C; Tsushima Y; Takagishi K
    Rheumatol Int; 2016 Jan; 36(1):109-15. PubMed ID: 26232929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Change of ARASHI scores for large joints in rheumatoid arthritis patients treated with abatacept for three years: A clinical observational study.
    Mochizuki T; Yano K; Ikari K; Hiroshima R; Ishibashi M; Okazaki K
    Arch Rheumatol; 2021 Mar; 36(1):10-18. PubMed ID: 34046564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-body FDG-PET/CT on rheumatoid arthritis of large joints.
    Kubota K; Ito K; Morooka M; Mitsumoto T; Kurihara K; Yamashita H; Takahashi Y; Mimori A
    Ann Nucl Med; 2009 Nov; 23(9):783-91. PubMed ID: 19834653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of an
    Lee SJ; Jeong JH; Lee CH; Ahn BC; Eun JS; Kim NR; Kang JW; Nam EJ; Kang YM
    Arthritis Rheumatol; 2019 Aug; 71(8):1232-1240. PubMed ID: 30771237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semi-quantitative analysis of
    Ravikanth R; Singh JK
    World J Nucl Med; 2020; 19(4):347-352. PubMed ID: 33623503
    [No Abstract]   [Full Text] [Related]  

  • 10. (18)F-FDG and (18)F-NaF PET/CT demonstrate coupling of inflammation and accelerated bone turnover in rheumatoid arthritis.
    Watanabe T; Takase-Minegishi K; Ihata A; Kunishita Y; Kishimoto D; Kamiyama R; Hama M; Yoshimi R; Kirino Y; Asami Y; Suda A; Ohno S; Tateishi U; Ueda A; Takeno M; Ishigatsubo Y
    Mod Rheumatol; 2016; 26(2):180-7. PubMed ID: 26140472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axillary lymph-node metabolic activity assessment on
    Dam TT; Okamura K; Nakajima T; Yonemoto Y; Suto T; Arisaka Y; Tomonaga H; Tachibana M; Tajika T; Vu LD; Chikuda H; Tsushima Y
    Scand J Rheumatol; 2020 Mar; 49(2):96-104. PubMed ID: 31578102
    [No Abstract]   [Full Text] [Related]  

  • 12. Demonstrating disease activity in patients with rheumatoid arthritis. Is 18F FDG PET a sensitive method?
    Karapolat I; Sertpoyraz F; Oncel G; Kobak S; Yalcin M; Kumanlioglu K
    Nuklearmedizin; 2013 Dec; 52(6):244-9. PubMed ID: 24081426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [(18)]F FDG PET/CT imaging to monitor the therapeutic effect of liposome-encapsulated prednisolone in experimental rheumatoid arthritis.
    van der Geest T; Metselaar JM; Gerrits D; van Lent PL; Storm G; Laverman P; Boerman OC
    J Control Release; 2015 Jul; 209():20-6. PubMed ID: 25902038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does periodontitis affect the treatment response of biologics in the treatment of rheumatoid arthritis?
    Tachibana M; Yonemoto Y; Okamura K; Suto T; Sakane H; Kaneko T; Dam TT; Okura C; Tajika T; Tsushima Y; Chikuda H
    Arthritis Res Ther; 2020 Jul; 22(1):178. PubMed ID: 32711580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDG PET Imaging of Extremities in Rheumatoid Arthritis.
    Dhawan R; Lokitz K; Lokitz S; Caldito G; Takalkar AM
    J La State Med Soc; 2016; 168(5):156-161. PubMed ID: 27797345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-resolution (18)F-FDG PET/CT for assessing disease activity in rheumatoid and psoriatic arthritis: findings of a prospective pilot study.
    Chaudhari AJ; Ferrero A; Godinez F; Yang K; Shelton DK; Hunter JC; Naguwa SM; Boone JM; Raychaudhuri SP; Badawi RD
    Br J Radiol; 2016 Jul; 89(1063):20160138. PubMed ID: 27109738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features of atlantoaxial involvement in patients with rheumatoid arthritis using
    Noguchi A; Kurita T; Matsuzawa K
    Clin Rheumatol; 2023 Jul; 42(7):1875-1884. PubMed ID: 37000282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive factors related to shoulder joint destruction in rheumatoid arthritis patients treated with biologics: A prospective study.
    Yonemoto Y; Okamura K; Kobayashi T; Kaneko T; Okura C; Suto T; Tachibana M; Tsushima Y; Takagishi K
    Mod Rheumatol; 2017 Jul; 27(4):587-592. PubMed ID: 27785938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in fluorodeoxyglucose positron emission tomography/computed tomography findings between elderly onset rheumatoid arthritis and polymyalgia rheumatica.
    Takahashi H; Yamashita H; Kubota K; Miyata Y; Okasaki M; Morooka M; Takahashi Y; Kaneko H; Kano T; Mimori A
    Mod Rheumatol; 2015 Jul; 25(4):546-51. PubMed ID: 25401232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors for radiographic progression of large joint damage in patients with rheumatoid arthritis treated with biological disease-modifying antirheumatic drugs (bDMARDs): Results of 3 to 4 years of follow-up.
    Nakajima A; Terayama K; Sonobe M; Aoki Y; Takahashi H; Akatsu Y; Taniguchi S; Yamada M; Kubota A; Nakagawa K
    Mod Rheumatol; 2019 Nov; 29(6):903-909. PubMed ID: 30285585
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.